Healthcare professionals are handing out fewer prescriptions for medications to help people who want to quit, as smoking rates fall to the lowest on record and smokers increasingly turn to e-cigarettes.
Additional side-effect monitoring is no longer required for the smoking cessation treatment varenicline (Champix), after a large multinational trial showed that the drug did not significantly increase the risk of neuropsychiatric events compared with nicotine patches or placebo.
The e-Voke electronic nicotine inhaler has been approved by the MHRA as a medicinal product, allowing it to be prescribed as an aid to smoking cessation once it becomes commercially available.
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Handy calculators and conversions for primary care.